QIA:FRA
Qiagen NV
€30.12
arrow_downward
-0.08%(-0.025) 1D
May 21, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QIA...
Open
€29.89
High
€30.48
Low
€29.85
Mkt. cap
6.22B
Avg. vol.
1.57K
Volume
1.14K
Dividend
0.99%
Quarterly dividend
€0.07
Ex-dividend date
Jul 7, 2026
P/E ratio
18.51
52-wk high
€48.80
52-wk low
€27.86
EPS
€1.63
Shares outstanding
226.24M
No. of employees
6K
News stories
From sources across the web
AD HOC NEWS
·
1 hour ago
Qiagen stock (NL0012169213): Shares rise after Q1 update and guidance reaffirmation
TradingView
·
8 hours ago
QIAGEN Stock Up on the Launch of AI-Powered Workflow Agent Platform
AD HOC NEWS
·
9 hours ago
Qiagen N.V. stock (NL0012169213): Outlook raised after Q1 2026 update and new AI assistant launch
Investing.com
·
1 day ago
Qiagen launches AI assistant for laboratory research
Profile
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
About Qiagen NV
CEOThierry Bernard
Employees5.5K
FoundedNov 29, 1984
HeadquartersVenlo, Limburg, Netherlands
SectorHealth care
Websiteqiagen.com
AI content may include mistakes. Learn more